Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
308.95
+4.97 (1.63%)
At close: Sep 24, 2026, 4:00 PM EDT
309.51
+0.56 (0.18%)
Pre-market: Sep 25, 2026, 7:32 AM EDT
Labcorp Holdings Revenue
Labcorp Holdings had revenue of $3.73B in the quarter ending June 30, 2026, with 5.78% growth. This brings the company's revenue in the last twelve months to $14.35B, up 6.41% year-over-year. In the year 2025, Labcorp Holdings had annual revenue of $13.95B with 7.25% growth.
Revenue (ttm)
$14.35B
Revenue Growth
+6.41%
P/S Ratio
1.75
Revenue / Employee
$202,085
Employees
71,000
Market Cap
25.06B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.95B | 942.80M | 7.25% |
| Dec 31, 2024 | 13.01B | 847.30M | 6.97% |
| Dec 31, 2023 | 12.16B | 297.70M | 2.51% |
| Dec 31, 2022 | 11.86B | -4.26B | -26.41% |
| Dec 31, 2021 | 16.12B | 2.14B | 15.33% |
| Dec 31, 2020 | 13.98B | 2.42B | 20.98% |
| Dec 31, 2019 | 11.55B | 221.40M | 1.95% |
| Dec 31, 2018 | 11.33B | 1.03B | 9.95% |
| Dec 31, 2017 | 10.31B | 666.20M | 6.91% |
| Dec 31, 2016 | 9.64B | 961.70M | 11.08% |
| Dec 31, 2015 | 8.68B | 2.67B | 44.39% |
| Dec 31, 2014 | 6.01B | 203.30M | 3.50% |
| Dec 31, 2013 | 5.81B | 136.90M | 2.41% |
| Dec 31, 2012 | 5.67B | 129.10M | 2.33% |
| Dec 31, 2011 | 5.54B | 538.40M | 10.76% |
| Dec 31, 2010 | 5.00B | 309.20M | 6.59% |
| Dec 31, 2009 | 4.69B | 189.50M | 4.21% |
| Dec 31, 2008 | 4.51B | 437.00M | 10.74% |
| Dec 31, 2007 | 4.07B | 477.40M | 13.30% |
| Dec 31, 2006 | 3.59B | 263.20M | 7.91% |
| Dec 31, 2005 | 3.33B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.98B |
| Quest Diagnostics | 11.56B |
| ICON Public Limited Company | 8.29B |
| Waters | 4.64B |
| IDEXX Laboratories | 4.55B |
| Illumina | 4.49B |
| Mettler-Toledo International | 4.13B |
| Charles River Laboratories International | 4.00B |
LH News
- 4 days ago - Labcorp price target raised to $365 from $350 at Truist - TheFly
- 9 days ago - Labcorp Holdings Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 14 days ago - Labcorp price target raised to $380 from $361 at UBS - TheFly
- 14 days ago - Labcorp price target raised to $330 from $320 at Barclays - TheFly
- 14 days ago - Labcorp Holdings Transcript: Investor Day 2026 - Transcripts
- 14 days ago - Labcorp Holdings Slides: FY 2026 - Filings
- 15 days ago - Labcorp provides long-term outlook through 2029 - TheFly
- 15 days ago - Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day - PRNewsWire